IDEAS home Printed from https://ideas.repec.org/a/gam/jecomi/v12y2024i6p146-d1412985.html
   My bibliography  Save this article

The Opportunity Cost of COVID-19 Deaths in the USA

Author

Listed:
  • Tuyen Pham

    (Voinovich School of Leadership and Public Service, Ohio University, Athens, OH 45701, USA)

  • Anirudh V. S. Ruhil

    (Voinovich School of Leadership and Public Service, Ohio University, Athens, OH 45701, USA)

  • G. Jason Jolley

    (Voinovich School of Leadership and Public Service, Ohio University, Athens, OH 45701, USA)

Abstract

The U.S. is currently the country with the highest number of COVID-19 deaths. By the second week of October 2021, over 700,000 people in the U.S. had died after contracting the virus. When estimating the cost and benefit of a COVID-19 prevention measure, the value of a statistical life (VSL) has been widely used as an approximation for the value of a lost life. However, VSL arguably overstates the costs of deaths caused by COVID-19 because VSL captures the private individual’s benefit, and it is the same for everyone regardless of where they live, their productivity, their age, and their gender. In this study, rather than looking at the cost of life loss due to COVID-19, we focus on the opportunity costs of COVID-19 deaths to society. The opportunity cost of COVID-19 deaths is defined as the combination of direct medical costs and the costs of lost potential lifetime earnings. Our analysis focuses on the period from March 2020 to October 2021. We then quantify the average opportunity cost of COVID-19 deaths across the U.S. and by state level.

Suggested Citation

  • Tuyen Pham & Anirudh V. S. Ruhil & G. Jason Jolley, 2024. "The Opportunity Cost of COVID-19 Deaths in the USA," Economies, MDPI, vol. 12(6), pages 1-19, June.
    • Handle: RePEc:gam:jecomi:v:12:y:2024:i:6:p:146-:d:1412985
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2227-7099/12/6/146/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2227-7099/12/6/146/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Adler, Matthew D. & Ferranna, Maddalena & Hammitt, James K. & Treich, Nicolas, 2021. "Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime," Journal of Health Economics, Elsevier, vol. 75(C).
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. James K. Hammitt, 2020. "Valuing mortality risk in the time of COVID-19," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 129-154, October.
    2. Adler, Matthew D. & Ferranna, Maddalena & Hammitt, James K. & Treich, Nicolas, 2021. "Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime," Journal of Health Economics, Elsevier, vol. 75(C).
    3. Hammitt, James K., 2022. "Prevention, Treatment, and Palliative Care: The Relative Value of Health Improvements under Alternative Evaluation Frameworks," TSE Working Papers 22-1339, Toulouse School of Economics (TSE).
    4. James K. Hammitt, 2022. "Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks," Post-Print hal-03965174, HAL.
    5. Hammitt, James K. & Treich, Nicolas, 2021. "Fatality Risk Regulation," TSE Working Papers 21-1177, Toulouse School of Economics (TSE).
    6. Robert E. Hall & Charles I. Jones & Peter J. Klenow, 2020. "Trading Off Consumption and COVID-19 Deaths," Quarterly Review, Federal Reserve Bank of Minneapolis, vol. 42(1), pages 1-14, June.
    7. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2024. "Quality- and productivity-adjusted life years: From QALYs to PALYs and beyond," Journal of Health Economics, Elsevier, vol. 95(C).
    8. Ferranna, Maddalena & Sevilla, J.P. & Bloom, David E., 2021. "Addressing the COVID-19 Pandemic: Comparing Alternative Value Frameworks," IZA Discussion Papers 14181, Institute of Labor Economics (IZA).
    9. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2023. "Productivity and quality-adjusted life years: QALYs, PALYs and beyond," Working Papers 11-2023, Copenhagen Business School, Department of Economics.
    10. Christian Gollier, 2020. "If the Objective is Herd Immunity, on Whom Should it be Built?," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 76(4), pages 671-683, August.
    11. Martin F. Quaas & Jasper N. Meya & Hanna Schenk & Björn Bos & Moritz A. Drupp & Till Requate, 2020. "The Social Cost of Contacts: Theory and Evidence for the Covid-19 Pandemic in Germany," CESifo Working Paper Series 8347, CESifo.
    12. Charles Shaw & Silvio Vanadia, 2022. "Utilitarianism on the front lines: COVID-19, public ethics, and the "hidden assumption" problem," Papers 2205.01957, arXiv.org.
    13. Da Costa, Shaun & O’Donnell, Owen & Van Gestel, Raf, 2024. "Distributionally sensitive measurement and valuation of population health," Journal of Health Economics, Elsevier, vol. 93(C).
    14. Nadia J. Sweis, 2022. "Revisiting the value of a statistical life: an international approach during COVID-19," Risk Management, Palgrave Macmillan, vol. 24(3), pages 259-272, September.
    15. Maddalena Ferranna & JP Sevilla & David E. Bloom, 2021. "Addressing the COVID-19 Pandemic: Comparing Alternative Value Frameworks," NBER Working Papers 28601, National Bureau of Economic Research, Inc.
    16. Bloom, David & Ferranna, Maddalena & Sevilla, JP, 2021. "Addressing the COVID-19 Pandemic: Comparing Alternative Value Frameworks," CEPR Discussion Papers 15904, C.E.P.R. Discussion Papers.
    17. Martin F Quaas & Jasper N Meya & Hanna Schenk & Björn Bos & Moritz A Drupp & Till Requate, 2021. "The social cost of contacts: Theory and evidence for the first wave of the COVID-19 pandemic in Germany," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-29, March.
    18. Hammitt, James K., 2022. "Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks," Journal of Health Economics, Elsevier, vol. 84(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jecomi:v:12:y:2024:i:6:p:146-:d:1412985. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.